MedPath

MOUNTAIN HOME RESEARCH & EDUCATION CORPORATION

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

2 Phases

Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 4
1 (50.0%)

Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI

Not Applicable
Not yet recruiting
Conditions
Dizziness
Mild Traumatic Brain Injury
First Posted Date
2024-01-24
Last Posted Date
2024-01-24
Lead Sponsor
Mountain Home Research & Education Corporation
Target Recruit Count
68
Registration Number
NCT06222450

Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty

Phase 4
Terminated
Conditions
Staphylococcal Infections
Methicillin-resistant Staphylococcus Aureus
Interventions
First Posted Date
2010-09-08
Last Posted Date
2014-02-03
Lead Sponsor
Mountain Home Research & Education Corporation
Target Recruit Count
28
Registration Number
NCT01196169
Locations
🇺🇸

Johnson City Medical Center, Johnson City, Tennessee, United States

🇺🇸

James H Quillen VA Medical Center, Mountain Home, Tennessee, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.